US$ 28.36
glp 1 oral medications FDA approves Foundayo, an GLP-1 alternative to Wegovy and Ozempic GLP-1 Drug Savings: A Complete
Description
Provider consultations: Monthly or quarterly telehealth visits may carry additional fees depending on your platform

This can result in vision changes such as blurry vision

Since Wegovy is already FDA-approved, Novo Nordisk announced on November 26th that they have filed their voucher for approval of a higher-dose version at 7.2mg
That is not a secondary benefit

GLP-1 medicines might slightly increase the risk of gallbladder disease

[DOI] [PubMed] [Google Scholar] 890.McCarty D., Coleman M., Boland C.L